Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Intrinsic Value
Shandong Pharmaceutical Glass Co., Ltd. engages in the research and development, production, and sale of medical glass packaging materials. [ Read More ]
The intrinsic value of one Shandong Pharmaceutical Glass Co Ltd stock under the Base Case scenario is 37.21 CNY. Compared to the current market price of 28.63 CNY, Shandong Pharmaceutical Glass Co Ltd is Undervalued by 23%.
Valuation Backtest
Shandong Pharmaceutical Glass Co Ltd
Run backtest to discover the historical profit from buying and selling Shandong Pharmaceutical Glass Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Shandong Pharmaceutical Glass Co Ltd's business.
What risks and challenges
does Shandong Pharmaceutical Glass Co Ltd face in the near future?
Summarize the latest earnings report
of Shandong Pharmaceutical Glass Co Ltd.
Provide P/E
for Shandong Pharmaceutical Glass Co Ltd and its competitors.
Balance Sheet Decomposition
Shandong Pharmaceutical Glass Co Ltd
Current Assets | 5.4B |
Cash & Short-Term Investments | 2.4B |
Receivables | 1.7B |
Other Current Assets | 1.2B |
Non-Current Assets | 3.7B |
Long-Term Investments | 50k |
PP&E | 2.9B |
Intangibles | 255.3m |
Other Non-Current Assets | 511m |
Current Liabilities | 1.6B |
Accounts Payable | 650.8m |
Accrued Liabilities | 18.3m |
Short-Term Debt | 586.9m |
Other Current Liabilities | 334m |
Non-Current Liabilities | 53.8m |
Other Non-Current Liabilities | 53.8m |
Earnings Waterfall
Shandong Pharmaceutical Glass Co Ltd
Revenue
|
4.9B
CNY
|
Cost of Revenue
|
-3.6B
CNY
|
Gross Profit
|
1.3B
CNY
|
Operating Expenses
|
-451.3m
CNY
|
Operating Income
|
814.7m
CNY
|
Other Expenses
|
-76.9m
CNY
|
Net Income
|
737.7m
CNY
|
Free Cash Flow Analysis
Shandong Pharmaceutical Glass Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Shandong Pharmaceutical Glass Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Shandong Pharmaceutical Glass Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shandong Pharmaceutical Glass Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
Shandong Pharmaceutical Glass Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shandong Pharmaceutical Glass Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Pharmaceutical Glass Co Ltd is 35.02 CNY with a low forecast of 34.34 CNY and a high forecast of 36.75 CNY.
Shareholder Return
Price
Shandong Pharmaceutical Glass Co Ltd
Average Annual Return | 20.96% |
Standard Deviation of Annual Returns | 51.36% |
Max Drawdown | -75% |
Market Capitalization | 19B CNY |
Shares Outstanding | 663 614 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shandong Pharmaceutical Glass Co., Ltd. engages in the research and development, production, and sale of medical glass packaging materials. The company is headquartered in Zibo, Shandong and currently employs 6,171 full-time employees. The company went IPO on 2002-06-03. The firm's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The firm distributes its products in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Shandong Pharmaceutical Glass Co Ltd stock under the Base Case scenario is 37.21 CNY.
Compared to the current market price of 28.63 CNY, Shandong Pharmaceutical Glass Co Ltd is Undervalued by 23%.